Hepatitis, Autoimmune Withdrawn Phase Trials for Budesonide (DB01222)

Also known as: Autoimmune hepatitis / Hepatitides, Autoimmune / Lupoid hepatitis NEC / Hepatitis autoimmune

IndicationStatusPhase
DBCOND0000794 (Hepatitis, Autoimmune)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00587119Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune HepatitisTreatment